候选DNA疫苗母体免疫可在免疫健全BALB/c小鼠中诱导针对出生后寨卡病毒感染的特定被动保护
本研究用表达寨卡病毒prM/E蛋白的DNA候选疫苗pVAX1-ZME免疫免疫健全雌性BALB/c小鼠,经体内电穿孔给予三剂50 μg后诱导了强效的寨卡病毒特异性细胞免疫和长期体液免疫,并产生高且持续的中和活性。母体免疫所产生的中和抗体对新生小鼠寨卡病毒感染提供特定被动保护,并有效抑制生长迟缓。
要点
- 三剂50 μg pVAX1-ZME经体内电穿孔诱导成年小鼠强效细胞免疫和长期体液免疫。
- 母体免疫的中和抗体对新生小鼠寨卡病毒感染提供特定被动保护。
- 母体免疫有效抑制新生小鼠寨卡病毒感染相关的生长迟缓。
核心结论
- 该候选疫苗有望在更高等动物中进一步评估,母体疫苗接种在保护育龄妇女及其后代免受出生后寨卡病毒感染方面显示出很大前景。
研究设计与样本
- 研究用表达寨卡病毒prM/E蛋白的DNA候选疫苗pVAX1-ZME免疫免疫健全雌性BALB/c小鼠,并评估母鼠免疫原性及对哺乳仔鼠的出生后保护。
主要发现
- 经体内电穿孔给予三剂50 μg pVAX1-ZME后,成年小鼠诱导了强效的寨卡病毒特异性细胞免疫和长期体液免疫,并产生高且持续的中和活性。
- 采用母体免疫方案,中和抗体对新生小鼠寨卡病毒感染提供特定被动保护,并有效抑制生长迟缓。
- 接种疫苗的母鼠和接受寨卡病毒攻击的仔鼠为在可用的完全免疫健全动物模型中评估寨卡疫苗提供了关键见解。
局限性
- 该候选疫苗有待在更高等动物中进一步评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Zika virus (ZIKV) infection is closely associated in the fetus with microcephaly and in the adults with Guillain-Barré syndrome and even male infertility. It is an urgent international priority to develop a safe and effective vaccine that offers protection to both women of childbearing age and their children. In this study, female immunocompetent BALB/c mice were immunized with a DNA-based vaccine candidate, pVAX1-ZME, expressing the prM/E protein of ZIKV, and the immunogenicity for maternal mice and the post-natal protection for suckling mice were evaluated. It was found that administration with three doses of 50 μg pVAX1-ZME via in vivo electroporation induced robust ZIKV-specific cellular and long-term humoral immune responses with high and sustained neutralizing activity in adult mice. Moreover, using a maternal immunization protocol, neutralizing antibodies provided specific passive protection against ZIKV infection in neonatal mice and effectively inhibited the growth delay. This vaccine candidate is expected to be further evaluated in higher animals, and maternal vaccination shows great promise for protecting both women of childbearing age and their offspring against post-natal ZIKV infection. The vaccinated mothers and ZIKV-challenged pups provide key insight into Zika vaccine evaluation in an available fully immunocompetent animal model.
引用
- Wang R, Liao X, Fan D, et al. Maternal immunization with a DNA vaccine candidate elicits specific passive protection against post-natal Zika virus infection in immunocompetent BALB/c mice. Vaccine. 2018. PMID: 29753607. doi:10.1016/j.vaccine.2018.04.051
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。